Advertisement
Screener

UFP Technologies, Inc. (UFPT) Investing Cash Flow

3.2 / 5 stars · 76/120 Roast Me

UFP Technologies, Inc. Investing Cash Flow

UFP Technologies, Inc. (UFPT) reported Investing Cash Flow of -$2.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06

  • UFP Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$1.10M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$1.69M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$3.86M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$15.27M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$27.60M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$210.16M.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$10.49M, a 912.39% decline from fiscal 2022.
  • UFP Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $1.29M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$2.79M
10-Q · filed 2026-08-06
-$6.65M
derived: sum of 3 quarters · filed 2026-08-06
-$21.92M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$1.69M
10-Q · filed 2026-05-08
-$5.54M
derived: sum of 2 quarters · filed 2026-05-08
-$20.82M
derived: sum of 3 quarters · filed 2026-05-08
-$26.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$3.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$19.13M
derived: sum of 2 quarters · filed 2026-02-27
-$24.78M
derived: sum of 3 quarters · filed 2026-08-06
-$27.60M
10-K · filed 2026-02-27
2025-09-30-$15.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$20.92M
derived: sum of 2 quarters · filed 2026-08-06
-$23.74M
10-Q · filed 2025-11-07
-$27.63M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$5.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$8.47M
10-Q · filed 2026-08-06
-$12.35M
derived: sum of 3 quarters · filed 2026-08-06
-$209.52M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$2.82M
10-Q · filed 2026-05-08
-$6.70M
derived: sum of 2 quarters · filed 2026-05-08
-$203.87M
derived: sum of 3 quarters · filed 2026-05-08
-$211.25M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$3.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$201.05M
derived: sum of 2 quarters · filed 2026-02-27
-$208.43M
derived: sum of 3 quarters · filed 2026-02-27
-$210.16M
10-K · filed 2026-02-27
2024-09-30-$197.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$204.55M
derived: sum of 2 quarters · filed 2025-11-07
-$206.28M
10-Q · filed 2025-11-07
-$209.04M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$7.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$9.11M
10-Q · filed 2025-08-11
-$11.87M
derived: sum of 3 quarters · filed 2026-02-27
-$14.65M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$1.73M
10-Q · filed 2025-05-12
-$4.49M
derived: sum of 2 quarters · filed 2026-02-27
-$7.27M
derived: sum of 3 quarters · filed 2026-02-27
-$10.04M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$2.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$5.54M
derived: sum of 2 quarters · filed 2026-02-27
-$8.31M
derived: sum of 3 quarters · filed 2026-02-27
-$10.49M
10-K · filed 2026-02-27
2023-09-30-$2.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$5.55M
derived: sum of 2 quarters · filed 2024-11-12
-$7.73M
10-Q · filed 2024-11-12
-$10.70M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$2.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$4.95M
10-Q · filed 2024-08-09
-$7.91M
derived: sum of 3 quarters · filed 2025-03-03
$25.49M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31-$2.18M
10-Q · filed 2024-05-10
-$5.14M
derived: sum of 2 quarters · filed 2025-03-03
$28.26M
derived: sum of 3 quarters · filed 2025-03-03
$22.09M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$2.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$30.43M
derived: sum of 2 quarters · filed 2025-03-03
$24.27M
derived: sum of 3 quarters · filed 2025-03-03
$1.29M
10-K · filed 2025-03-03
2022-09-30$33.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$27.23M
derived: sum of 2 quarters · filed 2023-11-09
$4.25M
10-Q · filed 2023-11-09
-$92.98M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$6.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$29.14M
10-Q · filed 2023-08-09
-$126.38M
derived: sum of 3 quarters · filed 2024-02-29
-$127.34M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$22.98M
10-Q · filed 2023-05-10
-$120.21M
derived: sum of 2 quarters · filed 2024-02-29
-$121.17M
derived: sum of 3 quarters · filed 2024-02-29
-$122.98M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$97.23M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29
-$98.20M
derived: sum of 2 quarters · filed 2024-02-29
-$100.01M
derived: sum of 3 quarters · filed 2024-02-29
-$101.46M
10-K · filed 2024-02-29
2021-09-30-$965.00K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14
-$2.78M
derived: sum of 2 quarters · filed 2022-11-14
-$4.23M
10-Q/A · filed 2022-11-14
-$5.54M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30-$1.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$3.26M
10-Q · filed 2022-08-09
-$4.57M
derived: sum of 3 quarters · filed 2023-03-16
-$5.40M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31-$1.45M
10-Q · filed 2022-05-10
-$2.76M
derived: sum of 2 quarters · filed 2023-03-16
-$3.59M
derived: sum of 3 quarters · filed 2023-03-16
-$4.70M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$2.14M
derived: sum of 2 quarters · filed 2023-03-16
-$3.25M
derived: sum of 3 quarters · filed 2023-03-16
-$4.26M
10-K · filed 2023-03-16
2020-09-30-$828.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$1.95M
derived: sum of 2 quarters · filed 2021-11-05
-$2.95M
10-Q · filed 2021-11-05
-$4.34M
derived: sum of 4 quarters · filed 2022-03-14
2020-06-30-$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$2.12M
10-Q · filed 2021-08-06
-$3.52M
derived: sum of 3 quarters · filed 2022-03-14
-$5.08M
derived: sum of 4 quarters · filed 2022-03-14
2020-03-31-$1.01M
10-Q · filed 2021-05-07
-$2.40M
derived: sum of 2 quarters · filed 2022-03-14
-$3.96M
derived: sum of 3 quarters · filed 2022-03-14
-$5.39M
derived: sum of 4 quarters · filed 2022-03-14
2019-12-31-$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
-$2.96M
derived: sum of 2 quarters · filed 2022-03-14
-$4.39M
derived: sum of 3 quarters · filed 2022-03-14
-$5.77M
10-K · filed 2022-03-14
2019-09-30-$1.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$2.99M
derived: sum of 2 quarters · filed 2020-11-06
-$4.38M
10-Q · filed 2020-11-06
-$5.29M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30-$1.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$2.82M
10-Q · filed 2020-08-07
-$3.73M
derived: sum of 3 quarters · filed 2021-03-12
-$5.25M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31-$1.39M
10-Q · filed 2020-05-08
-$2.29M
derived: sum of 2 quarters · filed 2021-03-12
-$3.82M
derived: sum of 3 quarters · filed 2021-03-12
-$5.29M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31-$907.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$2.43M
derived: sum of 2 quarters · filed 2021-03-12
-$3.90M
derived: sum of 3 quarters · filed 2021-03-12
-$82.33M
10-K · filed 2021-03-12
2018-09-30-$1.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$2.99M
derived: sum of 2 quarters · filed 2019-11-08
-$81.42M
10-Q · filed 2019-11-08
-$84.92M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30-$1.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$79.90M
10-Q · filed 2019-08-09
-$83.40M
derived: sum of 3 quarters · filed 2020-03-13
-$85.81M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31-$78.43M
10-Q · filed 2019-05-10
-$81.93M
derived: sum of 2 quarters · filed 2020-03-13
-$84.34M
derived: sum of 3 quarters · filed 2020-03-13
-$87.35M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31-$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$5.91M
derived: sum of 2 quarters · filed 2020-03-13
-$8.92M
derived: sum of 3 quarters · filed 2020-03-13
-$10.38M
10-K · filed 2020-03-13
2017-09-30-$2.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$5.42M
derived: sum of 2 quarters · filed 2018-11-09
-$6.87M
10-Q · filed 2018-11-09
-$8.30M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$3.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$4.46M
10-Q · filed 2018-08-09
-$5.89M
derived: sum of 3 quarters · filed 2019-03-15
2017-03-31-$1.46M
10-Q · filed 2018-05-10
-$2.89M
derived: sum of 2 quarters · filed 2019-03-15
2016-12-31-$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$7.19M
10-K · filed 2019-03-15
2016-09-30-$5.76M
10-Q · filed 2017-11-09
2015-12-31-$15.69M
10-K · filed 2018-03-16
2011-06-30$213.44K
10-Q · filed 2011-08-10
2010-06-30-$873.08K
10-Q · filed 2011-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57